Accord BioPharma’s Vision for 2022: Looking Beyond

By Chrys Kokino, President, Accord BioPharma?

As we reflect on the past two years, it’s abundantly apparent that a clear understanding of the present healthcare landscape is necessary to empower a brighter future. The COVID-19 pandemic has affected us all and it has taught us to look beyond—to understand the people facing disease and how their identities and lived experiences might affect their disease management.??

It’s time for us to recognize these factors in interactions with patients. The treatment experience is often transactional; the delivery of therapies is frequently thought of as a one-off exchange between company or provider and patient. At a time when patients are increasingly making themselves and their needs heard, we shouldn’t settle for the status quo. We must look beyond the biology of medicine to see disease from a patient’s perspective and meet those patients at each phase of their journeys. At Accord BioPharma, that is exactly what we aim to do.??

As a biopharma company with an entrepreneurial spirit backed by the resources of our parent company, Intas Pharmaceuticals, we’re uniquely positioned to nimbly address challenges that stakeholders face along any of these touchpoints. We strive to consider the viewpoints of each group with which we partner and provide a fair, balanced approach to our business. Together, we’re working to overcome barriers and provide an enhanced patient experience in the areas of oncology, immunology, and critical care.???

Drug development is not just about a scientific approach, but about pursuing innovative thinking in healthcare. This means optimizing and evolving existing treatment options and always asking how we can improve upon a product, a process, or an idea. A perfect example of this philosophy at work: the anticipated upcoming launch of our first innovative product in a few weeks.?

The reason for activating on patient insights is simple; you can have an effective treatment on the market, but if the patients who need it dislike the manner in which it is delivered or cannot easily adhere to it, they’re no better off—and neither is our business. That’s why our philosophy is to bring therapies to market that improve upon currently available products. Our medicines should bring something new to the table—and they have to be accessible, too.??

We approach meeting unmet needs by to taking what exists and going beyond the status quo. The team at Accord BioPharma is intellectually curious, creative, and imaginative. We like to see the world from new perspectives. We are listening to what patients, providers, and partners think and say, driving us to form genuine relationships at every level. And we’re always looking to expand our network.??

Our people empower us to make that impact; our people are our difference. We’re comprised of a group of diverse but aligned individuals who are all dedicated to enhancing the patient experience. Free of the processes and politics you may find at larger pharmaceutical companies, we are capable of working quickly and efficiently to address the challenges we encounter. We seek and hire people who want to help people, people who can think freely and feel deeply, and people who will exercise empathy in their internal and external interactions.??

We look forward to sharing more with you as we progress our pipeline and continue to bring high-quality therapies to market. Our promise is this: an undying commitment to going beyond the biology of medicine to more effectively reach and meet the needs of patients, providers, and partners, to prioritize access and affordability, and to continue improving the treatment experience in every therapeutic area we touch.?

?